|
dna metabolic process
|
GO:0006259 |
303 |
0.829
|
Human |
|
protection from non homologous end joining at telomere
|
GO:0031848 |
4 |
0.737
|
|
|
telomere maintenance in response to dna damage
|
GO:0043247 |
4 |
0.713
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
45 |
0.520
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.468
|
Human |
|
telomere capping
|
GO:0016233 |
4 |
0.428
|
|
|
dna replication
|
GO:0006260 |
52 |
0.351
|
Human |
|
chromatin modification
|
GO:0016568 |
187 |
0.288
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
48 |
0.267
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.259
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.236
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.228
|
|
|
dna biosynthetic process
|
GO:0071897 |
22 |
0.227
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
58 |
0.217
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.215
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.213
|
|
|
chromosome segregation
|
GO:0007059 |
48 |
0.205
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.193
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.188
|
|
|
dna endoreduplication
|
GO:0042023 |
4 |
0.170
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.165
|
|
|
histone threonine phosphorylation
|
GO:0035405 |
1 |
0.154
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.150
|
Human |
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.150
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.149
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.146
|
Human |
|
cell division
|
GO:0051301 |
120 |
0.135
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.132
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.126
|
|
|
dna repair
|
GO:0006281 |
107 |
0.124
|
Human |
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.117
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.117
|
Human |
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.114
|
Human |
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.112
|
Human |
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.112
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.111
|
Human |
|
mitotic sister chromatid segregation
|
GO:0000070 |
14 |
0.110
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.106
|
|
|
dna packaging
|
GO:0006323 |
30 |
0.105
|
|
|
mitotic nuclear division
|
GO:0007067 |
48 |
0.103
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.102
|
|
|
female meiosis chromosome segregation
|
GO:0016321 |
1 |
0.097
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.097
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.096
|
Human |
|
translesion synthesis
|
GO:0019985 |
1 |
0.093
|
|
|
cell cycle checkpoint
|
GO:0000075 |
47 |
0.091
|
Human |
|
centrosome separation
|
GO:0051299 |
4 |
0.091
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.086
|
Human |
|
regulation of nuclear cell cycle dna replication
|
GO:0033262 |
2 |
0.086
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.085
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.084
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.084
|
Human |
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.083
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.082
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.081
|
Human |
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.080
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.072
|
Human |
|
negative regulation of cell cycle process
|
GO:0010948 |
69 |
0.070
|
|
|
negative regulation of dna replication
|
GO:0008156 |
4 |
0.068
|
|
|
gonad development
|
GO:0008406 |
141 |
0.068
|
|
|
regulation of mitosis
|
GO:0007088 |
29 |
0.066
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.066
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.065
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.064
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.062
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.061
|
Human |
|
protein maturation
|
GO:0051604 |
176 |
0.060
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.060
|
Human |
|
methylation
|
GO:0032259 |
134 |
0.059
|
|
|
sister chromatid segregation
|
GO:0000819 |
20 |
0.059
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.059
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.058
|
Human |
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.057
|
Human |
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.057
|
|
|
genitalia development
|
GO:0048806 |
37 |
0.057
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.056
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.055
|
Human |
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.055
|
Human |
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.054
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.052
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.052
|
|
|
gene silencing
|
GO:0016458 |
38 |
0.052
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.052
|
|
|
protein processing
|
GO:0016485 |
163 |
0.051
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.051
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.051
|
Human |
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.051
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.048
|
Human |
|
metaphase anaphase transition of mitotic cell cycle
|
GO:0007091 |
9 |
0.048
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.047
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.047
|
Human |
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.047
|
|
|
synapsis
|
GO:0007129 |
34 |
0.046
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.046
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.045
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.044
|
Human |
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.044
|
Human |
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.044
|
Human |
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.043
|
Human |
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.043
|
Human |
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.043
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.042
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.042
|
|
|
mitotic cell cycle checkpoint
|
GO:0007093 |
31 |
0.042
|
|
|
spindle assembly involved in mitosis
|
GO:0090307 |
4 |
0.041
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.041
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.041
|
Human |
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.041
|
Human |
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.040
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.040
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.040
|
Human |
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.039
|
Human |
|
regulation of dna dependent dna replication
|
GO:0090329 |
8 |
0.039
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.039
|
|
|
mitotic recombination
|
GO:0006312 |
3 |
0.039
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.038
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.038
|
Human |
|
negative regulation of cell division
|
GO:0051782 |
24 |
0.038
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.038
|
Human |
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.036
|
|
|
dna recombination
|
GO:0006310 |
92 |
0.036
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.036
|
Human |
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.035
|
|
|
mitotic sister chromatid separation
|
GO:0051306 |
9 |
0.035
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.035
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.035
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.035
|
|
|
dna replication independent nucleosome assembly
|
GO:0006336 |
1 |
0.035
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.035
|
Human |
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.035
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
57 |
0.034
|
|
|
regulation of nuclear division
|
GO:0051783 |
56 |
0.034
|
|
|
mitotic chromosome condensation
|
GO:0007076 |
1 |
0.033
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.033
|
Human |
|
histone modification
|
GO:0016570 |
159 |
0.033
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.032
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.032
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.032
|
|
|
regulation of mitotic sister chromatid segregation
|
GO:0033047 |
12 |
0.031
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.031
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.031
|
|
|
chromosome separation
|
GO:0051304 |
14 |
0.031
|
|
|
regulation of dna replication
|
GO:0006275 |
17 |
0.031
|
Human |
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.030
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.030
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
61 |
0.030
|
|
|
protein polymerization
|
GO:0051258 |
57 |
0.030
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.030
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.029
|
Human |
|
urogenital system development
|
GO:0001655 |
261 |
0.029
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.029
|
Human |
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.028
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.028
|
|
|
positive regulation of chromosome organization
|
GO:2001252 |
33 |
0.028
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.028
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.028
|
Human |
|
negative regulation of chromosome organization
|
GO:2001251 |
30 |
0.027
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.027
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.027
|
|
|
negative regulation of mitosis
|
GO:0045839 |
10 |
0.027
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.027
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.027
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.027
|
Human |
|
astral microtubule organization
|
GO:0030953 |
3 |
0.027
|
|
|
spindle checkpoint
|
GO:0031577 |
12 |
0.027
|
|
|
cation transport
|
GO:0006812 |
399 |
0.027
|
|
|
chromatin remodeling at centromere
|
GO:0031055 |
2 |
0.026
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.026
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.026
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.026
|
|
|
protein dna complex subunit organization
|
GO:0071824 |
28 |
0.026
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.026
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.026
|
Human |
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.026
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.026
|
|
|
heterochromatin organization
|
GO:0070828 |
4 |
0.025
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
57 |
0.025
|
|
|
negative regulation of homeostatic process
|
GO:0032845 |
71 |
0.025
|
|
|
protein localization to chromosome
|
GO:0034502 |
6 |
0.025
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.025
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.025
|
Human |
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.025
|
Human |
|
dna conformation change
|
GO:0071103 |
37 |
0.024
|
Human |
|
centrosome cycle
|
GO:0007098 |
23 |
0.024
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.024
|
|
|
mitotic sister chromatid cohesion
|
GO:0007064 |
1 |
0.024
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.024
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.024
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.024
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.024
|
|
|
nuclear dna replication
|
GO:0033260 |
3 |
0.024
|
|
|
positive regulation of meiosis i
|
GO:0060903 |
5 |
0.024
|
|
|
gland development
|
GO:0048732 |
330 |
0.024
|
|
|
regulation of proteasomal ubiquitin dependent protein catabolic process
|
GO:0032434 |
40 |
0.023
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.023
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.023
|
|
|
synaptonemal complex assembly
|
GO:0007130 |
13 |
0.023
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.023
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
98 |
0.023
|
|
|
chromatin assembly or disassembly
|
GO:0006333 |
16 |
0.022
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.022
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.022
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.022
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.022
|
|
|
fertilization
|
GO:0009566 |
127 |
0.021
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.021
|
Human |
|
negative regulation of sister chromatid segregation
|
GO:0033046 |
7 |
0.021
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.021
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.021
|
Human |
|
dna alkylation
|
GO:0006305 |
43 |
0.021
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.021
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.021
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.020
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.020
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.020
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.020
|
|
|
placenta development
|
GO:0001890 |
140 |
0.020
|
|
|
positive regulation of microtubule polymerization or depolymerization
|
GO:0031112 |
3 |
0.020
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.020
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.020
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
88 |
0.020
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.020
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.020
|
|
|
regulation of histone modification
|
GO:0031056 |
56 |
0.020
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.020
|
|
|
meiotic chromosome segregation
|
GO:0045132 |
19 |
0.020
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.020
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.019
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.019
|
|
|
rna interference
|
GO:0016246 |
2 |
0.019
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.019
|
|
|
cell cycle g2 m phase transition
|
GO:0044839 |
20 |
0.019
|
|
|
microtubule organizing center organization
|
GO:0031023 |
28 |
0.019
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.019
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.018
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.018
|
Human |
|
spermatid differentiation
|
GO:0048515 |
115 |
0.018
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.018
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.018
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.018
|
|
|
anion transport
|
GO:0006820 |
177 |
0.018
|
|
|
rna dependent dna replication
|
GO:0006278 |
3 |
0.018
|
|
|
microtubule cytoskeleton organization involved in mitosis
|
GO:1902850 |
4 |
0.018
|
|
|
positive regulation of mitotic cell cycle
|
GO:0045931 |
41 |
0.018
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.018
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.018
|
Human |
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.018
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.017
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.017
|
|
|
dna methylation
|
GO:0006306 |
43 |
0.017
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
74 |
0.017
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.017
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.017
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.017
|
|
|
mitotic cytokinesis
|
GO:0000281 |
4 |
0.017
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.017
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.017
|
|
|
double strand break repair via homologous recombination
|
GO:0000724 |
21 |
0.017
|
|
|
dna modification
|
GO:0006304 |
50 |
0.017
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.017
|
Human |
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.017
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.017
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.016
|
|
|
meiosis i
|
GO:0007127 |
60 |
0.016
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.016
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.016
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.016
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.016
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
57 |
0.016
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.016
|
|
|
spindle organization
|
GO:0007051 |
28 |
0.016
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.015
|
|
|
chromatin assembly
|
GO:0031497 |
13 |
0.015
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.015
|
|
|
regulation of meiosis i
|
GO:0060631 |
7 |
0.015
|
|
|
positive regulation of cell division
|
GO:0051781 |
31 |
0.015
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.015
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.015
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.015
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.015
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.015
|
|
|
spindle assembly involved in meiosis
|
GO:0090306 |
4 |
0.015
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.015
|
|
|
double strand break repair
|
GO:0006302 |
48 |
0.014
|
Human |
|
mesodermal cell migration
|
GO:0008078 |
4 |
0.014
|
|
|
histone h3 k9 acetylation
|
GO:0043970 |
5 |
0.014
|
|
|
metaphase plate congression
|
GO:0051310 |
2 |
0.014
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.014
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.014
|
|
|
cell aging
|
GO:0007569 |
35 |
0.014
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.014
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.014
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.014
|
|
|
regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903050 |
56 |
0.014
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.014
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.014
|
|
|
positive regulation of nuclear division
|
GO:0051785 |
27 |
0.014
|
|
|
spindle assembly involved in female meiosis
|
GO:0007056 |
3 |
0.014
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.014
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.014
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.014
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.014
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.014
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.014
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.014
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.014
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.013
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.013
|
|
|
negative regulation of nuclear division
|
GO:0051784 |
19 |
0.013
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.013
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.013
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.013
|
|
|
dna ligation
|
GO:0006266 |
3 |
0.013
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.013
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.013
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.013
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.013
|
|
|
mrna processing
|
GO:0006397 |
63 |
0.013
|
|
|
anaphase promoting complex dependent proteasomal ubiquitin dependent protein catabolic process
|
GO:0031145 |
9 |
0.013
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.013
|
|
|
striated muscle myosin thick filament assembly
|
GO:0071688 |
1 |
0.013
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.013
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.013
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.013
|
|
|
histone phosphorylation
|
GO:0016572 |
9 |
0.013
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.012
|
|
|
single fertilization
|
GO:0007338 |
82 |
0.012
|
|
|
regulation of chromosome segregation
|
GO:0051983 |
21 |
0.012
|
|
|
atp metabolic process
|
GO:0046034 |
75 |
0.012
|
Human |
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.012
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.012
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.012
|
|
|
reciprocal meiotic recombination
|
GO:0007131 |
16 |
0.012
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.012
|
|
|
chorion development
|
GO:0060717 |
7 |
0.012
|
|
|
regulation of proteasomal protein catabolic process
|
GO:0061136 |
46 |
0.012
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.012
|
|
|
positive regulation of protein complex assembly
|
GO:0031334 |
45 |
0.012
|
|
|
humoral immune response
|
GO:0006959 |
57 |
0.012
|
|
|
sister chromatid cohesion
|
GO:0007062 |
12 |
0.012
|
|
|
reciprocal dna recombination
|
GO:0035825 |
16 |
0.012
|
|
|
regulation of cell cycle g2 m phase transition
|
GO:1902749 |
10 |
0.012
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.012
|
|
|
histone acetylation
|
GO:0016573 |
41 |
0.012
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.012
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.012
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.012
|
|
|
positive regulation of cytoskeleton organization
|
GO:0051495 |
49 |
0.012
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.012
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.012
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.012
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.012
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.012
|
|
|
nucleic acid phosphodiester bond hydrolysis
|
GO:0090305 |
49 |
0.012
|
Human |
|
negative regulation of mitotic sister chromatid segregation
|
GO:0033048 |
7 |
0.012
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.011
|
|
|
negative regulation of meiotic cell cycle phase transition
|
GO:1901994 |
3 |
0.011
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.011
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.011
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.011
|
|
|
tube formation
|
GO:0035148 |
140 |
0.011
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.011
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.011
|
|
|
dna integrity checkpoint
|
GO:0031570 |
28 |
0.011
|
Human |
|
centromere complex assembly
|
GO:0034508 |
3 |
0.011
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.011
|
|
|
negative regulation of mitotic metaphase anaphase transition
|
GO:0045841 |
7 |
0.011
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.011
|
|
|
cellularization
|
GO:0007349 |
1 |
0.011
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.011
|
|
|
retrograde transport endosome to golgi
|
GO:0042147 |
2 |
0.011
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.011
|
|
|
peptidyl threonine modification
|
GO:0018210 |
31 |
0.011
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.011
|
|
|
g2 m transition of mitotic cell cycle
|
GO:0000086 |
20 |
0.011
|
|
|
pharynx development
|
GO:0060465 |
1 |
0.011
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.011
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.011
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.011
|
|
|
protein localization to chromatin
|
GO:0071168 |
3 |
0.011
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.011
|
|
|
apoptotic nuclear changes
|
GO:0030262 |
9 |
0.011
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.011
|
|
|
positive regulation of histone modification
|
GO:0031058 |
28 |
0.011
|
|
|
telomere maintenance
|
GO:0000723 |
19 |
0.011
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.010
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.010
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.010
|
|
|
action potential
|
GO:0001508 |
78 |
0.010
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.010
|
|
|
dna dependent dna replication maintenance of fidelity
|
GO:0045005 |
3 |
0.010
|
|
|
cell growth
|
GO:0016049 |
130 |
0.010
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.010
|
|
|
telomere maintenance via telomerase
|
GO:0007004 |
1 |
0.010
|
|
|
dna catabolic process exonucleolytic
|
GO:0000738 |
3 |
0.010
|
Human |
|
wound healing
|
GO:0042060 |
157 |
0.010
|
|
|
spindle assembly
|
GO:0051225 |
13 |
0.010
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.010
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.010
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.010
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.010
|
|